Polyrizon

PLRZ · NASDAQ

$9.15−$0.535 (−5.52%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $9.69

About PLRZ

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The company is headquartered in Ra'Anana, Central(Hamerkaz) and currently employs 1 full-time employees. The company went IPO on 2024-10-29. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..

Employees: 1
Headquarters: Ra'anana, Central(HaMerkaz)
Listed: Oct 29, 2024
Sector: Health Care
Industry: Biotechnology
Website: polyrizon-biotech.com

Leadership

Polyrizon executives
Name	Title	Since	Age
Tomer Izraeli	—	2005	46
Nir Ben Yosef	—	—	49
Daphna Avital	—	—	58
Tidhar Turgeman	—	—	48
Eyal Ron	—	—	69
Oz Adler	—	—	39
Liron Carmel	—	—	40
Asaf Itzhaik	—	—	52
Liat Sidi	—	—	50
Omer Srugo	—	—	30
Yehonatan Vinokur	—	—	46

Similar companies

Companies in the same industry as Polyrizon

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.